Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15-55 years and first-time modelling of antibody responses in mature women: results from an open-label 6-year follow-up study. [electronic resource]
Producer: 20150305Description: 107-18 p. digitalISSN:- 1471-0528
- Adolescent
- Adult
- Age Factors
- Antibodies, Viral -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Human papillomavirus 16 -- immunology
- Human papillomavirus 18 -- immunology
- Humans
- Middle Aged
- Papillomavirus Infections -- prevention & control
- Papillomavirus Vaccines -- immunology
- Uterine Cervical Neoplasms -- prevention & control
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.